Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 568 Records) |
Query Trace: Lung Neoplasms and TP53[original query] |
---|
Clonality Analysis for the Relationship between the Pulmonary Combined Neuroendocrine Carcinoma and "the So-Called Reported Histologic Transformation". Cancers 2023 12 15 (23): . Haiyue Wang, Yanli Zhu, Wei Sun, Xin Yang, Xinying Liu, Kaiwen Chi, Xiaozheng Huang, Lixin Zhou, Weijing Cai, Dongmei L |
Comparison of the somatic genomic landscape between central- and peripheral-type non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2023 12 187 107439. Lei Wang, Meng Diao, Zheng Zhang, Minlin Jiang, Shifu Chen, Deping Zhao, Zhenguo Liu, Caicun Zh |
Higher TP53 somatic mutation prevalence from liquid biopsy analysis in ever smoker non-small-cell lung cancer patients. Mutation research 2023 12 828 111847. Haktan Ba??? Erdem, Mustafa Tar?k Alay, Zeynep Özdemir, Ezgi Çevik, Öztürk Ate?, Cengiz Karaçin, ?brahim ?ahin, Mutlu Do?an, Taha Bah |
The enrichment of Fanconi anemia/homologous recombination pathway aberrations in ATM/ATR-mutated NSCLC was accompanied by unique molecular features and poor prognosis. Journal of translational medicine 2023 12 21 (1): 874. Wei Wei, Fangfang Shi, Yang Xu, Yang Jiao, Ying Zhang, Qiuxiang Ou, Xue Wu, Lingyi Yang, Jinhuo L |
Comparison of gene mutation profile in different lung adenocarcinoma subtypes by targeted next-generation sequencing. Medical oncology (Northwood, London, England) 2023 11 40 (12): 349. Shaowen Zhang, Ping Dong, Zongwei Pan, Qian Chen, Junqi Zhu, Zhangfan M |
SMARCA4?deficient non?small cell lung cancer with an EGFR mutation: A case report. Oncology letters 2023 11 26 (6): 513. Lijun Sun, Qiong Fu, Lijiang Chen, Meijuan Di, Jianhua C |
Pathogenic germline variants in BRCA1 and TP53 increase lung cancer risk in Chinese. Cancer medicine 2023 11 . Bing Wei, Jiadong Zhao, Jun Li, Junnan Feng, Manman Sun, Zhizhong Wang, Chao Shi, Ke Yang, Yue Qin, Jing Zhang, Jie Ma, Hui Do |
Correlation analysis of clinical, pathological, imaging and genetic features of ground-glass nodule featured lung adenocarcinomas between high-risk and non-high-risk individuals. European journal of medical research 2023 11 28 (1): 478. Jing Ren, Yuan Wang, Chunrong Liu, Lan Yang, Xinlu Men, Zhixin Q |
DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients. Diagnostic pathology 2023 11 18 (1): 119. Weiguang Gu, Wenya Zhuang, Mengxia Zhuang, Minhong He, Zhihua |
Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers. Targeted oncology 2023 11 . Marine Marchal, Vincent Leroy, Hélène Behal, Eric Dansin, Nicolas Paris, Soraya Bordier, Sarah Humez, Fabienne Escande, Clément Gauvain, Alexis B Cort |
Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic Alterations. Cancers 2023 11 15 (22): . Soojin Jun, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Juhee Cho, Hyun Ae Ju |
Combination of genomic instability score and TP53 status for prognosis prediction in lung adenocarcinoma. NPJ precision oncology 2023 11 7 (1): 110. Juan Feng, Yang Lan, Feng Liu, Ye Yuan, Jia Ge, Sen Wei, Hu Luo, Jianjun Li, Tao Luo, Xiuwu Bi |
Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases. Journal of neuro-oncology 2023 10 . Kaixuan Bai, Xin Chen, Xuejiao Qi, Yu Zhang, Yueli Zou, Jian Li, Lili Yu, Yuanyuan Li, Jiajia Jiang, Yi Yang, Yajing Liu, Shuanghao Feng, Hui |
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers. Cancer cell 2023 10 . Evelyn Jiagge, Dexter X Jin, Justin Y Newberg, Tomin Perea-Chamblee, Kelly R Pekala, Christopher Fong, Michele Waters, David Ma, Yvonne Dei-Adomakoh, Gilles Erb, Kanika S Arora, Sophia L Maund, Njoki Njiraini, Atara Ntekim, Susie Kim, Xuechun Bai, Marlene Thomas, Ronwyn van Eeden, Priti Hegde, Justin Jee, Debyani Chakravarty, Nikolaus Schultz, Michael F Berger, Garrett M Frampton, Ethan S Sokol, Jian Carrot-Zha |
Comparative analysis of batch correction methods for FDG PET/CT using metabolic radiogenomic data of lung cancer patients. Scientific reports 2023 10 13 (1): 18247. Hyunjong Lee, Sujin Seo, Sungho Won, Woong-Yang Park, Joon Young Choi, Kyung-Han Lee, Se-Hoon Lee, Seung Hwan Mo |
NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study. Molecular oncology 2023 10 . Satoshi Ikeda, Masahiro Tsuboi, Kazuko Sakai, Toshihiro Misumi, Hiroaki Akamatsu, Hiroyasu Shoda, Noriaki Sakakura, Atsushi Nakamura, Yasuhisa Ohde, Hidetoshi Hayashi, Kyoichi Okishio, Morihito Okada, Ichiro Yoshino, Jiro Okami, Kazuhisa Takahashi, Norihiko Ikeda, Masayuki Tanahashi, Yuichi Tambo, Haruhiro Saito, Shinichi Toyooka, Hidetoshi Inokawa, Toyofumi Chen-Yoshikawa, Toshihide Yokoyama, Tatsuro Okamoto, Noriko Yanagitani, Masahide Oki, Makoto Takahama, Kenji Sawa, Hirohito Tada, Kazuhiko Nakagawa, Tetsuya Mitsudomi, Kazuto Nish |
Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer. International journal of cancer 2023 10 . Ard van Veelen, G D Marijn Veerman, Marjon V Verschueren, Judith L Gulikers, Christi M J Steendam, Anita J W M Brouns, Safiye Dursun, Marthe S Paats, Vivianne C G Tjan-Heijnen, Cor van der Leest, Anne-Marie C Dingemans, Ron H J Mathijssen, Ewoudt M W van de Garde, Patrick Souverein, Johanna H M Driessen, Lizza E L Hendriks, Robin M J M van Geel, Sander Cro |
Correlation Analysis of the TP53 Mutation With Clinical Characteristics in the Prognosis of Non-Small Cell Lung Cancer. Clinical Medicine Insights. Oncology 2023 10 17 11795549231184918. Lihuan Zhu, Dongsheng Zhou, Yiyong Chen, Tianxing Guo, Wenshu Chen, Xiaojie P |
Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways. Computers in biology and medicine 2024 4 174 108346. Salvatore D'Antona, Danilo Porro, Francesca Gallivanone, Gloria Berto |
Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 4 . Ying Fu, Qing Liu, Xiaohan Wang, Liangchao Sun, Xiao Han, Xue Me |
Prevalence and Associations of Co-occurrence of NFE2L2 Mutations and Chromosome 3q26 Amplification in Lung Cancer. Global medical genetics 2024 4 11 (2): 150-158. Jinfeng Liu, Sijie Liu, Dan Li, Hongbin Li, Fan Zha |
Exploration of efficacy of different therapy regimens for advanced NSCLC patients with KRAS mutation in the first-line treatment. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 4 . Ke Wang, Manyi Xu, Yanhua Wang, Chunwei Xu, Yue Hao, Zhengbo So |
Non-invasive decision support for clinical treatment of non-small cell lung cancer using a multiscale radiomics approach. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2024 1 191 110082. Xingping Zhang, Guijuan Zhang, Xingting Qiu, Jiao Yin, Wenjun Tan, Xiaoxia Yin, Hong Yang, Hua Wang, Yanchun Zha |
Clinical and molecular profiling of EGFR-mutant lung adenocarcinomas transformation to small cell lung cancer during TKI treatment. Frontiers in oncology 2024 1 13 1308313. Yongxia Chen, Mengye He, Zhengfeng Dai, Yina Wang, Jing Chen, Xiaoting Wang, Xiao Dong, Jianfei Huang, Jian Ruan, Xiaochen Zhang, Peng Shen, Yunlu J |
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors. The journal of pathology. Clinical research 2024 1 10 (2): e354. Michael Menzel, Martina Kirchner, Klaus Kluck, Markus Ball, Susanne Beck, Michael Allgäuer, Christin Assmann, Johannes Schnorbach, Anna-Lena Volckmar, Timothy Kwang Yong Tay, Hannah Goldschmid, Daniel Sw Tan, Michael Thomas, Daniel Kazdal, Jan Budczies, Albrecht Stenzinger, Petros Christopoul |
First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations. European journal of cancer (Oxford, England : 1990) 2024 1 199 113556. Miriam Blasi, Jonas Kuon, Heike Lüders, Daniel Misch, Diego Kauffmann-Guerrero, Moritz Hilbrandt, Daniel Kazdal, Roger-Fei Falkenstern-Ge, Björn Hackanson, Sebastian Dintner, Martin Faehling, Martina Kirchner, Anna-Lena Volckmar, Hans-Georg Kopp, Michael Allgäuer, Christian Grohé, Amanda Tufman, Martin Reck, Nikolaj Frost, Albrecht Stenzinger, Michael Thomas, Petros Christopoul |
Genomic profiling of relapsed small cell lung cancer reveals potential pathways of therapeutic targets. Journal of thoracic disease 2024 1 15 (12): 6796-6805. Wen Ouyang, Jing Yu, Zihang Zeng, Jun Gong, Junhong Zhang, Conghua X |
Prognostic Impact of TP53 Mutations in Metastatic Nonsquamous Non-small-cell Lung Cancer. Clinical lung cancer 2024 1 . Laurent Mathiot, Benoit Nigen, Thomas Goronflot, Sandrine Hiret, Ludovic Doucet, Elvire Pons-Tostivint, Jaafar Bennouna, Marc G Denis, Guillaume Herbreteau, Judith Raimbou |
Effectiveness and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in non-small cell lung cancer (NSCLC). Translational lung cancer research 2024 1 12 (12): 2448-2459. Dae-Ho Choi, Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Se-Hoon L |
Prognostic Significance of Tumor Mutation Burden among Patients with Non-small Cell Lung Cancer Who Received Platinum-based Adjuvant Chemotherapy: An Exploratory Study. Journal of cancer prevention 2024 1 28 (4): 175-184. Wei-Xi Shen, Guang-Hua Li, Yu-Jia Li, Peng-Fei Zhang, Jia-Xing Yu, Di Shang, Qiu-Shi Wa |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: